The key issue is to send eye swabs in clinical situations where it can make a difference to management, and limiting the use of eye swabs in routine cases of conjunctivitis which are likely to be due ...

Chlamydia – caused by the organism Chlamydia trachomatis – caused an estimated 128.5 million new infections in 2020, according to the World Health Organization (WHO), with a global prevalence ...

It was like metaphor turned reality. After 130 days spent fighting the federal government, Elon Musk turned up with a black eye at the White House on Friday for his last day as a “special ...

Circle Eyes $7.2B Valuation in Upsized U.S. IPO Amid Strong Investor Demand Circle raises its IPO share count and price range as strong investor demand fuels interest.

Trump 2.0 falls apart before our eyes The president is losing it . By Brian Karem White House columnist. Published May 29, 2025 9:02AM (EDT) ...

What happened to Elon Musk eye? After being asked by a reporter during a presser at the White House, Musk said the bruise on his right eye was cause by his 5-year-old son, X.

Evil Eye is the latest proof that Dan Da Dan is anime’s ultimate genre chameleon, effortlessly shifting tones and styles in an instant. This time, it leans deeper into its horror roots ...

Methicillin-resistant Staphylococcus aureus (MRSA) is a type of bacteria that usually lives on the skin. However, it can cause eye infections that range from mild to severe. Staphylococcus aureus ...

All eyes are on Nvidia (NASDAQ: NVDA) today as it prepares to report earnings. Why is the report such a big deal? For a couple of reasons. Nvidia dominates an area that drove stock market gains ...

Elon Musk said the black eye he was sporting in his Oval Office goodbye May 30 came from "horsing around" with his 5-year-old son, X. "I said, 'Go ahead, punch me in the face.' And he did it ...

Musk explains his black eye, says he told son X to punch him Elon Musk attributed his bruised appearance at a White House news conference to his son. “I said, ‘Go ahead, punch me in the face.’ ...

The U.S. Food and Drug Administration has approved the first-in-class TRPM8 receptor agonist Tryptyr (acoltremon ophthalmic solution) for the treatment of signs and symptoms of dry eye disease.